After trials on two groups of volunteers, Russia’s Gamaleya Research Centre announced it has created the first vaccine against COVID-19. According to Russian Health Minister Mikhail Murashko, the first batch of the drug, known as "Sputnik-V", will be produced in 2 weeks and delivered for voluntary vaccination in Russian hospitals.
The vaccine is a two-component treatment based on the human adenovirus, which, according to scientists, makes people develop immunity to the virus for at least two years.
In a first substantial breakthrough in India for Moscow-based Gamaleya Institute vaccine Sputnik V, the multinational pharmaceutical company Dr. Reddy’s announced that it will be distributing 100 million doses of vaccine in India after conducting final-stage human trials and receiving regulatory clearances.
MOSCOW (Sputnik) - Sri Lanka's Ambassador to Moscow Meegahalande Durage Lamawansa said on Monday he planned getting inoculated with Russia's vaccine against COVID-19, dubbed Sputnik V, in the near future.
MOSCOW (Sputnik) - The distinguished medical journal, The Lancet, has published correspondence authored by four Russian researchers at the Gamaleya Scientific Research Institute of Epidemiology and Microbiology written in response to an appeal made by global scientists to clarify issues raised over the clinical trials of Russia's Sputnik V vaccine.
MOSCOW (Sputnik) - Russian pharmaceutical company Promomed is in talks with neighbouring countries, Latin America, and Africa to supply them with Areplivir drug that can help in the COVID-19 treatment, the director-general of the company, Andrey Mladentsev, said.
BERLIN (Sputnik) - Germany would like to get more information about the Russian vaccine against COVID-19, Health Minister Jens Spahn said on Tuesday.
Earlier, Moscow and Manila struck an agreement to jointly work on clinical trials of the first coronavirus vaccine, Sputnik V. The Philippine president has even volunteered to be the first to test the Russian vaccine in his country.
Earlier this month, Russian President Vladimir Putin and King Salman of Saudi Arabia discussed the prospects of the joint development of the Russian vaccine, which was registered in August.
BELGRADE (Sputnik) - The authorities in North Macedonia are exploring the possibility of procuring Russia’s Sputnik V vaccine against COVID-19 following consultations with Moscow, the Russian Embassy in Skopje stated on Saturday.
LONDON (Sputnik) – The pharmaceutical company AstraZeneca announced on Saturday that it has resumed the clinical trials for its COVID-19 vaccine, after receiving permission from UK health regulators, following a pause triggered by a sudden illness in one of the participants.
The pharmaceutical company Landsteiner Scientific has signed an agreement with the Russian Direct Investment Fund (RDIF) to purchase and distribute 32 million doses of the Russian vaccine Sputnik V in Mexico. Sputnik discussed the issue with the laboratory’s medical director Alejandro Lara.
MOSCOW (Sputnik) - Margarita Simonyan, the editor-in-chief of the Sputnik news agency, RT broadcaster and the Rossiya Segodnya international news agency, said on Friday she had been inoculated with Russia's Sputnik V coronavirus vaccine.
MOSCOW (Sputnik) - The Russian Direct Investment Fund, one of the entities behind the Russian coronavirus vaccine Sputnik V, plans to supply up to 100 million doses of the vaccine to various countries across Latin America, the company's chief executive officer, Kirill Dmitriev, said on Thursday.
The world's first anti-COVID-19 vaccine Sputnik V was registered in Russia on 11 August, following several rounds of clinical trials and has now been made available to the public across the country. More than a dozen countries have now expressed interest in obtaining the vaccine.
Earlier in the day, AstraZeneca announced that the third round of its trials of an anti-COVID-19 vaccine has been paused following the “potentially unexplained illness” of a participant in the UK.
The third round of trials for the AstraZeneca anti-COVID-19 drug is now on pause over “potentially unexplained illness” in a participant in the UK. On 11 August, Russia registered its own Sputnik V anti-coronavirus vaccine, which is said to have been developed in a different way.
The first batch of the Russian vaccine against COVID-19, developed by the Gamaleya Centre, has already been made available for public use, the Russian Health Ministry said early on Tuesday.
On 11 August, the world's first vaccine against the COVID-19 coronavirus 'Sputnik V' was registered by the Russian government, developed by the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF).
The Russian Health Ministry registered the first vaccine against COVID-19, named Sputnik V, on 11 August.
Since the launch on August 11 of the Sputnik V COVID-19 vaccine, developed by Gamaleya Center scientists, Russia has seen immense interest and expressions of hope from many countries and has received requests for 1 billion doses of the vaccine.